200 related articles for article (PubMed ID: 35884569)
1. Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.
van de Velde ME; Uittenboogaard A; Yang W; Bonten E; Cheng C; Pei D; van den Berg MH; van der Sluis IM; van den Bos C; Abbink FCH; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Evans WE; Kaspers GJL
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884569
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy.
Sawaki A; Miyazaki K; Yamaguchi M; Takeuchi T; Kobayashi K; Imai H; Tawara I; Ono R; Nosaka T; Katayama N
Int J Hematol; 2020 May; 111(5):686-691. PubMed ID: 31993939
[TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology Patients.
van de Velde ME; Panetta JC; Wilhelm AJ; van den Berg MH; van der Sluis IM; van den Bos C; Abbink FCH; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Evans WE; Kaspers GL
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635465
[TBL] [Abstract][Full Text] [Related]
4. CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.
Skiles JL; Chiang C; Li CH; Martin S; Smith EL; Olbara G; Jones DR; Vik TA; Mostert S; Abbink F; Kaspers GJ; Li L; Njuguna F; Sajdyk TJ; Renbarger JL
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115708
[TBL] [Abstract][Full Text] [Related]
5. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review.
van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH
Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739
[TBL] [Abstract][Full Text] [Related]
6. Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.
Centanni M; van de Velde ME; Uittenboogaard A; Kaspers GJL; Karlsson MO; Friberg LE
Clin Pharmacokinet; 2024 Feb; 63(2):197-209. PubMed ID: 38141094
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Early-Onset Peripheral Neuropathy Caused by Vincristine in Patients With a First Administration of R-CHOP or R-CHOP-Like Chemotherapy.
Okada N; Hanafusa T; Sakurada T; Teraoka K; Kujime T; Abe M; Shinohara Y; Kawazoe K; Minakuchi K
J Clin Med Res; 2014 Aug; 6(4):252-60. PubMed ID: 24883150
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer: A Systematic Review and Meta-Analysis.
Uittenboogaard A; Neutel CLG; Ket JCF; Njuguna F; Huitema ADR; Kaspers GJL; van de Velde ME
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158880
[TBL] [Abstract][Full Text] [Related]
9. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial).
van de Velde ME; Kaspers GJL; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; van den Berg MH
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322788
[TBL] [Abstract][Full Text] [Related]
10. Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.
Yang QY; Hu YH; Guo HL; Xia Y; Zhang Y; Fang WR; Li YM; Xu J; Chen F; Wang YR; Wang TF
Front Pharmacol; 2021; 12():771487. PubMed ID: 34955843
[TBL] [Abstract][Full Text] [Related]
11. The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer.
van de Velde ME; van den Berg MH; Kaspers GJL; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; van Litsenburg RRL
Cancer Med; 2021 Nov; 10(22):8172-8181. PubMed ID: 34725942
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous quantification and pharmacokinetics of vincristine and its major metabolite M1 in Chinese pediatric ALL patients by LC-MS/MS.
Yuan Y; Chen C; You G; Yao R; Zhu X; Wu X; Wu J; Zhao W; Li Z; Zhang S
J Pharm Biomed Anal; 2023 Sep; 234():115578. PubMed ID: 37459833
[TBL] [Abstract][Full Text] [Related]
13. Genetic factors influencing the development of vincristine-induced neurotoxicity.
Pozzi E; Fumagalli G; Chiorazzi A; Canta A; Cavaletti G
Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):215-226. PubMed ID: 33283553
[No Abstract] [Full Text] [Related]
14. Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts.
Wu CY; Li GT; Chu CC; Guo HL; Fang WR; Li T; Wang YR; Xu J; Hu YH; Zhou L; Chen F
Arch Toxicol; 2023 Feb; 97(2):377-392. PubMed ID: 36418572
[TBL] [Abstract][Full Text] [Related]
15. Severe Vincristine-Induced Neuropathic Pain: A Case Report with Pharmacogenetic Analysis and Literature Review.
Hu YH; Li GZ; Long JY; Yang QY; Zhang Y; Chen F; Wang YR
Pharmgenomics Pers Med; 2022; 15():1029-1035. PubMed ID: 36605068
[TBL] [Abstract][Full Text] [Related]
16. Vincristine-induced peripheral neuropathy: A mini-review.
Li GZ; Hu YH; Li DY; Zhang Y; Guo HL; Li YM; Chen F; Xu J
Neurotoxicology; 2020 Dec; 81():161-171. PubMed ID: 33053366
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis).
Uittenboogaard A; van den Berg MH; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Kaspers GJL; van de Velde ME
Cancer Med; 2023 Oct; 12(19):19480-19490. PubMed ID: 37732486
[TBL] [Abstract][Full Text] [Related]
18. Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment.
Triarico S; Romano A; Attinà G; Capozza MA; Maurizi P; Mastrangelo S; Ruggiero A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923421
[TBL] [Abstract][Full Text] [Related]
19. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
20. Vincristine-induced peripheral neuropathy in pediatric cancer patients.
Mora E; Smith EM; Donohoe C; Hertz DL
Am J Cancer Res; 2016; 6(11):2416-2430. PubMed ID: 27904761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]